Overview Consumer Health Products Law and Compliance Issues

Size: px
Start display at page:

Download "Overview Consumer Health Products Law and Compliance Issues"

Transcription

1 Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services

2 Consumer Health Products Agenda Overview of Applicable Law and Codes Current issues / Compliance Challenges Categories Covered Over the Counter Medications ( OTCs ) Cosmetics Health/Dietary Supplements/Nutritionals Medical Devices 2

3 Framework for OTCs Increased incidence of self-medication Better public health through easy access (e.g. smoking cessation) Savings in healthcare costs (resources used more efficiently) 3

4 OTCs: Regulatory Principles Key Control Mechanisms (a) Proper labelling (to provide consumer with relevant information) (API, Indications, Safety) (b) Advertising Control (via self or co-regulatory systems) (Truthful claims, Not misleading) (c) Restrictions on retail outlets 4

5 OTCs Classification as a means of control OTCs make medication more readily available without physician s intervention OTCs can be further classified generally into: (i) (ii) Pharmacy only General sales list Rx products can also be reclassified (at manufacturer s initiation) into OTC status 5

6 OTCs (cont d) Subject to same general regulatory regime as drugs (marketing approval) (e.g. Drugs Act, Pharmaceutical Affairs Act) Due to safer medical profile, manufacturer can typically request for waiver of clinical data submission, subject to meeting certain criteria. Regulatory approval also utilises concept of reference agencies (Australia TGA, US FDA, UK MHRA) and standard reference texts (on the use of active ingredient) 6

7 OTCs (cont d) Industry Associations World Self-Medication Industry (WSMI) U.S.A CHPA (Consumer Healthcare Products Association) CHPA has its own voluntary code and guidelines Asia Pacific Australia, China, Taiwan, Indonesia, Japan, Korea, Malaysia and New Zealand 7

8 OTCs: Ongoing Issues Methamphetamine ( Meth ) and Pseudoephedrine ( PDE ) Abuse PDE widely used OTC decongestant which can be used to manufacture Meth Meth illegal and highly addictive drug U.S legislation: Combat Meth Epidemic Act (2006) 8

9 Cosmetics Definition A Cosmetic Product is any substance of preparation that is intended to be placed in contact with the various external parts of the human body or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly cleaning them, perfuming them, changing their appearance, correcting body odours, protecting them or keeping them in good condition. - Includes lotions, gels and oral care products 9

10 Cosmetics Regulatory Regime Often times, manufacturers market a cosmetic product (with drug/health claims) without adhering to drug regulatory laws. Cosmeceutical a product which is both a drug and a cosmetic. No legal meaning but suggests that product may have some therapeutic effect. 10

11 Cosmetics Regulatory Regime (cont d) USA FDA is the regulatory authority Applicable Law (i) Federal Food Drug & Cosmetic Act (ii) Fair Packaging & Labelling Act ASEAN Cosmetic Directive To harmonise the regulation of cosmetics in the region Member states to ensure that only cosmetics which conform to Directive can be put onto the market. Manufacturer/Supplier has obligation to notify relevant regulator of place of manufacture or of initial importation before general sale. 11

12 ASEAN Directive Standardised labelling requirements Information required include the following: Functions Instructions for use Full ingredients for listing Manufacturing / Expiry date Special precautions if any 12

13 Hot Issues Poor compliance with advertising standards in certain segments: (i) (ii) efficiency claims for skin creams (cumulative claims) ultra-scientific claims (e.g. cell regeneration) (iii) dermatologist tested claims (what does this really mean) 13

14 Health/Dietary Supplements/Regulatory Regime Definition Product that is taken by mouth and contains dietary ingredient intended to supplement diet. Dietary Ingredients ( DI ) include vitamins, minerals, herbs, amino acids, any substance to supplement diet by increasing total dietary intakes (e.g. enzymes) AP region: Regulatory regime governed by combination of: Food Laws Regulations from local FDA Consumer Protection Laws 14

15 Singapore: Health Supplements Guidelines Guidelines define Health Supplements to include: (i) (ii) Traditional Medicines Health Foods (with vague and general medicinal claims) Working Definition A product used to supplement a diet, with benefits beyond those of normal nutrients, and/or to support/maintain healthy functions of the body. No pre-marketing approval system in place. 15

16 HS: Claims Guidelines Claims must be consistent with definition of HS Cannot be advertised for medicinal purpose (treatment or prevention, implied or otherwise of any disease or disorder) Must not be misleading or which cannot be adequately substantial Labelling Guidance 16

17 HS: Nutritional Health Claims (General) Permitted provided they contain well-documented ingredients which function is supported in standard reference texts and is adequately substantiated. Include (a) general health maintenance (b) vitamin and/or mineral supplementation (c) supports healthy function of human body 17

18 Medical Devices Definition a product/device that is represented for use by humans or is part of a class of substances, preparations or devices intended for use by humans solely or principally for health-related purposes Includes simple bandages, surgery equipment, medical diagnostic equipment 18

19 Regulatory Regime Not as complicated as pharmaceutical regulation. Where regime is in place, marketing authorisations are required. Classification system is risk-based. Various industry associations: e.g. AdvaMed (Advance Medical Technology Association) but no single global association to cover entire industry. 19

20 Medical Devices: Compliance Issues Ethical collaboration with HCPs to advance medical technology. HCP: innovators/having equity ownership. FCPA focus 20

21 Q&A Thank You!

Similarity & Difference in OTC Classification and their Borderlines among Asia Pacific

Similarity & Difference in OTC Classification and their Borderlines among Asia Pacific Similarity & Difference in OTC Classification and their Borderlines among Asia Pacific Dr. Noppadon (Nhum) Adjimatera South East Asia (SEA) Regulatory & Medical Affairs Director, RB, SEA, Thailand 22 October

More information

FDA Regulation of Claims on Dietary Supplement and Food Products

FDA Regulation of Claims on Dietary Supplement and Food Products FDA Regulation of Claims on Dietary Supplement and Food Products Patricia Kaeding August 2004 Topics FDA Overview What are claims Why claims matter Categories of claims Regulatory requirements for types

More information

Outline of presentation.

Outline of presentation. E-Siong Tee, PhD Nutrition Advisor, Ministry of Health Malaysia Outline of presentation. Provide an overview of current status and recent regulatory developments in nutrition labeling, nutrition and health

More information

TGA: the current regulatory reform agenda

TGA: the current regulatory reform agenda TGA: the current regulatory reform agenda ASMI 2012 Conference: 13 November 2012 Future proofing the consumer healthcare industry Dr John Skerritt, National Manager The Therapeutic Goods Administration

More information

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation 2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,

More information

An update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading

An update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading Sugar, salt and fat: strategies to reduce consumption Nutritional labelling: standards, guides and regulations An update on the regulatory framework for labelling across the EU Dr David Jukes Department

More information

Guideline for Advertising of e-cigarettes

Guideline for Advertising of e-cigarettes GUIDELINE 43 Guideline for Advertising of e-cigarettes Last Updated May 2015 What kind of product is this guideline for? What is the purpose of this guideline? Electronic, or e-cigarettes, are battery

More information

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP Getting Your Ingredient to Market: Understanding Your Regulatory Options 2013 Venable LLP 1 Overview of the Governing Laws 1. The Federal Food, Drug, and Cosmetic Act ("FD&C Act"): Requires foods, cosmetics,

More information

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy

More information

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS Introduction The ECR Asia Pacific OSA working group conducted an online survey between July and September 2011 aimed at gaining insights

More information

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer CHE8000 Major Research Project A The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer Completed by: Lina Karlina (ID: 2067226) Lina Karlina (2067226)

More information

Guideline on the Regulation of Therapeutic Products in New Zealand

Guideline on the Regulation of Therapeutic Products in New Zealand Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This

More information

Outline of presentation.

Outline of presentation. 1 E-Siong Tee, PhD Scientific Director, ILSI Southeast Asia Region Outline of presentation. Nutrient addition: voluntary and mandatory fortification of micronutrients Status of regulations in 7 SEA countries

More information

Policy Options for the Regulation of Electronic Cigarettes

Policy Options for the Regulation of Electronic Cigarettes Policy Options for the Regulation of Electronic Cigarettes Consultation submission This submission was completed by: (name) Position (if applicable): Evon Currie General Manager, Community and Public Health

More information

Policy Options for the Regulation of Electronic Cigarettes

Policy Options for the Regulation of Electronic Cigarettes Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: (name) Philip Hope / Assoc Prof Chris Atkinson Address: (street/box number)

More information

The Safety and Effectiveness of Dietary Supplements

The Safety and Effectiveness of Dietary Supplements Assignment 4 The Safety and Effectiveness of Dietary Supplements In Depth: Supplements Supplements, according to the FDA, are a product containing ingredients like vitamins, minerals, herms, amino acids,

More information

General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme

General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme asean General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme Ten Nations One Community www.aseansec.org Association of Southeast Asian Nations General Information Booklet on the

More information

Singapore OTC Switching Regulation

Singapore OTC Switching Regulation Singapore OTC Switching Regulation Roy Shyng Director, Regulatory Affairs Johnson & Johnson Asia Pacific Pte. Ltd. 10 th WSMI AP Regional Conference: Phuket, Thailand, Oct 014 1 Singapore Drug Forensic

More information

REGULATIONS IN FOOD INGREDIENTS

REGULATIONS IN FOOD INGREDIENTS REGULATIONS IN FOOD INGREDIENTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com Catherine

More information

ASEAN Health Supplements Regulatory Harmonisation Update

ASEAN Health Supplements Regulatory Harmonisation Update ASEAN Health Supplements Regulatory Harmonisation Update Daniel Quek Health Supplements Industry Association of Singapore ASEAN Alliance of Health Supplement Industry Associations @ IADSA AGM in Istanbul,Turkey

More information

Guidelines to Commission Regulation (EU) No 655/2013. laying down common criteria for the justification of claims used

Guidelines to Commission Regulation (EU) No 655/2013. laying down common criteria for the justification of claims used Ref. Ares(2015)5892153-16/12/2015 Version July 2013 Guidelines to Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products

More information

ADVANCED TECHNOLOGY CONFERENCE. The definition of a cosmeceutical. Anthony C. Dweck Research Director, Peter Black Medicare Ltd.

ADVANCED TECHNOLOGY CONFERENCE. The definition of a cosmeceutical. Anthony C. Dweck Research Director, Peter Black Medicare Ltd. ADVANCED TECHNOLOGY CONFERENCE The definition of a cosmeceutical Anthony C. Dweck Research Director, Peter Black Medicare Ltd. Introduction What on earth is a cosmeceutical? Is it an attempt to convince

More information

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov

More information

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment

More information

7 Day Food Evaluation

7 Day Food Evaluation 7 Day Food Evaluation The 7-day food evaluation allows us to look closely at the foods that you eat and what might be causing a reaction in your body or your child s body. We also encourage you to include

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No. Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 Submitted by: Submitted electronically to: Complementary Medicines

More information

Fostering Harmonization of Labelling and Claims in ASEAN Industry Perspective

Fostering Harmonization of Labelling and Claims in ASEAN Industry Perspective Fostering Harmonization of Labelling and Claims in ASEAN Industry Perspective Déjà vu, and Google! Found it! Summary of Seminar and Workshop on Nutrition Labelling and Health Claims, 5 6 April 2001, Singapore

More information

Improvising Claims. - Dr. R. B. Smarta

Improvising Claims. - Dr. R. B. Smarta Improvising Claims - Dr. R. B. Smarta Labelling is usually perceived as an important aspect in informing the consumers about the contents of food/nutraceuticals in the finished products. Claims allow the

More information

How to change the legal classification of a medicine in New Zealand

How to change the legal classification of a medicine in New Zealand How to change the legal classification of a medicine in New Zealand Guidance document Medsafe October 2017 Page 1 of 15 Contents Purpose and scope... 3 Definitions... 3 Background and legislative context...

More information

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis

More information

Scientific Exchange: What Every Compliance Officer Should Consider

Scientific Exchange: What Every Compliance Officer Should Consider Scientific Exchange: What Every Compliance Officer Should Consider Saul B. Helman, M.D October 21, 2015 The Sixteenth Pharmaceutical Compliance Congress and Best Practices Forum DISPUTES & INVESTIGATIONS

More information

Ornsurang Teerawat

Ornsurang Teerawat ASEAN TRADITIONAL MEDICINES AND HEALTH SUPPLEMENTS REGULATORY AND HARMONIZATION UPDATE Ornsurang Teerawat 21.10.2014 \ http://trainstudenytp.wordpress.com ACCSQ (ASEAN Consultative Committee for Standard

More information

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER Food for Thought JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER CLINOPS DAG, 12 APRIL 2018 HISTORY OF RESEARCH AND DEVELOPMENT

More information

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003 OXYCONTIN Diversion & Abuse Office of Diversion Control October 2003 OXYCONTIN OxyContin is a controlled release form of Schedule II oxycodone Manufactured in tablet form and intended for oral ingestion

More information

Which was the greatest problem with patent medicines in early America that lead to drug legislation?

Which was the greatest problem with patent medicines in early America that lead to drug legislation? Pharmacology Connections to Nursing Practice 3rd Edition Adams Test Bank Full Download: http://testbanklive.com/download/pharmacology-connections-to-nursing-practice-3rd-edition-adams-test-bank/ Adams

More information

WHO Framework Convention on Tobacco Control

WHO Framework Convention on Tobacco Control WHO Framework Convention on Tobacco Control When WHO was established in 1948, its Member States incorporated the power to negotiate treaties into its Constitution. This power remained dormant until 1996,

More information

OVERVIEW OF THE 2017 VFD PROGRAM

OVERVIEW OF THE 2017 VFD PROGRAM OVERVIEW OF THE 2017 VFD PROGRAM Iowa Department of Agriculture and Land Stewardship Jeff Verzal, Compliance Investigator BACKGROUND In 1996 Congress passed Federal Law stating that medicated feeds which

More information

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs) Complementary Medicines Australia submission to the Therapeutic Goods Administration Consultation: Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs) 12 January 2018 To:

More information

AUSTRALIAN MADE CAMPAIGN LIMITED

AUSTRALIAN MADE CAMPAIGN LIMITED AUSTRALIAN MADE CAMPAIGN LIMITED PHARMACEUTICALS AND COMPLEMENTARY HEALTHCARE PRODUCTS - COMPLIANCE POLICY May 2018 Summary Made Campaign Limited (AMCL) is the t-for-profit organisation which administers

More information

A Family Medicine Cabinet

A Family Medicine Cabinet A Family Medicine Cabinet What is a medicine? There is no generally accepted definition for the word medicine. Most people use the word medicine to refer to products that affect how the body functions.

More information

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center

More information

Coventry Health Care of Georgia, Inc.

Coventry Health Care of Georgia, Inc. Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan

More information

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No. VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;

More information

N. BUNYAPRAPHATSARA. ASEAN Harmonization on Traditional Medicine and Health Supplement Registration Requirement

N. BUNYAPRAPHATSARA. ASEAN Harmonization on Traditional Medicine and Health Supplement Registration Requirement N. BUNYAPRAPHATSARA ASEAN Harmonization on Traditional Medicine and Health Supplement Registration Requirement ASEAN Brunei Indonesia Malaysia Philippines Singapore Thailand Cambodia Laos Myanmar Vietnam

More information

Tobacco control: Best practices. Tara Singh Bam The Union Asia Pacific, Singapore

Tobacco control: Best practices. Tara Singh Bam The Union Asia Pacific, Singapore Tobacco control: Best practices Tara Singh Bam The Union Asia Pacific, Singapore tsbam@theunion.org http://www.worldtobacco.co.uk/asia/ Indonesia is a recognized tobaccofriendly market with no smoking

More information

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG

More information

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products UNITED STATES REGULATION OF TOBACCO PRODUCTS Presented by Mitch Zeller Center Director FDA Center for Tobacco Products May 24, 2016 OVERVIEW OF TODAY S PRESENTATION Highlights of the Deeming Final Rule

More information

How to Regulate E-Cigarettes? Are we asking the right questions?

How to Regulate E-Cigarettes? Are we asking the right questions? How to Regulate E-Cigarettes? Are we asking the right questions? Eric N. Lindblom Director, Tobacco Control and Food & Drug Law O Neill Institute for National & Global Health Law Georgetown University

More information

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement Claims about health in ads for e-cigarettes CAP and BCAP s regulatory statement Contents 1. Executive Summary... 2 2. Policy background and the decision to consult... 4 3. Decisions... 6 4. Consequence

More information

Policy Options for the Regulation of Electronic Cigarettes

Policy Options for the Regulation of Electronic Cigarettes Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: Address: (name) Mark Forsyth (street/box number) 3 Queens Wharf (town/city)

More information

The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of

The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of UNIT 11 INVESTIGATE WESTERN HERBAL PRODUCTS HISTORY OF TRADITIONAL WESTERN HERBAL MEDICINE The father of Western medicine, Hippocrates (460 BC - 377 BC) is known to have used many plants and herbs for

More information

Animal Products Notice

Animal Products Notice Animal Products Notice Labelling Requirements for Exports of Dairy Based Infant Formula Products and Formulated Supplementary Food for Young Children 18 December 2014 An animal products notice issued under

More information

Nutritional Criteria for Labeling Claims

Nutritional Criteria for Labeling Claims Nutritional Criteria for Labeling Claims Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements Center for Food Safety and Applied Nutrition/ Food and Drug Administration Department

More information

U.S. FDA Perspective on Food Supplements/TM

U.S. FDA Perspective on Food Supplements/TM U.S. FDA Perspective on Food Supplements/TM IKHLAS A. KHAN National Center for Natural Products Research, Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy,

More information

TOBACCO PRODUCT OR MEDICAL PRODUCT?

TOBACCO PRODUCT OR MEDICAL PRODUCT? TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:

More information

The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016

The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016 INFORMATION NOTE INTENDED FOR KNOWLEDGE HUB The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016 This note is to alert you to the fact that the English Statutory

More information

PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY

PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY OBJECTIVES What is the difference between herbal supplements, over the counter medicines, and prescription medicines?

More information

REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA

REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA TAN JAS MIN National Pharmaceutical Regulatory Agency Ministry of Health Malaysia Email address: tanjasmin@npra.gov.my ORGANISATION

More information

European Food Safety Authority

European Food Safety Authority AF 01.10.2004 3a Discussion paper on Botanicals European Food Safety Authority SCIENTIFIC COMMITTEE Brussels, 25 June 2004 EFSA/SC/26 Final Discussion Paper on Botanicals and Botanical Preparations widely

More information

REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?

REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN? REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN? Rosanna Tarricone, PhD Associate Dean, Government Health and Non Profit Division Issue Panel Opportunities and challenges in international

More information

Update on the revision of the new package leaflet (PL) template. An agency of the European Union

Update on the revision of the new package leaflet (PL) template. An agency of the European Union Update on the revision of the new package leaflet (PL) template An agency of the European Union Contents Regulatory background New QRD package leaflet template -Origin - Contents and structure 2 Regulatory

More information

The global regulatory environment for health claims with particular emphasis on Asia

The global regulatory environment for health claims with particular emphasis on Asia The global regulatory environment for health claims with particular emphasis on Asia How food regulations are changing the way we market our products Patrick Coppens Regional Director EAS Europe & MEA

More information

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center

More information

Guidance Document. 9 May A guidance document issued by the Ministry for Primary Industries

Guidance Document. 9 May A guidance document issued by the Ministry for Primary Industries Guidance Document Labelling of retail-ready dairybased infant formula products and formulated supplementary food for young children intended for export 9 May 2018 A guidance document issued by the Ministry

More information

From Wikipedia, the free encyclopedia

From Wikipedia, the free encyclopedia 1 of 6 11/24/2010 11:43 PM From Wikipedia, the free encyclopedia The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United

More information

Smoking Cessation: A readily modifiable risk factor

Smoking Cessation: A readily modifiable risk factor Robert L. Keith MD FCCP Associate Professor of Medicine Medical Director of Respiratory Therapy Eastern Colorado Health Care System University of Colorado Denver Smoking Cessation: A readily modifiable

More information

Industry and globalisation of herbal medicines

Industry and globalisation of herbal medicines TradReg 2017 Bonn 14 September 2017 Industry and globalisation of herbal medicines Dr Hubertus Cranz Director General Association of the European Self-Medication Industry (AESGP) 7 Avenue de Tervuren,

More information

Decoding the Confusing Language of Vitamins. Yuliya Klopouh, M.H., Pharm.D

Decoding the Confusing Language of Vitamins. Yuliya Klopouh, M.H., Pharm.D Decoding the Confusing Language of Vitamins Yuliya Klopouh, M.H., Pharm.D Nutritional Supplements ( Vitamins, etc) History of Dietary supplements 1990 Nutritional Labeling and Education Act Permitted use

More information

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS SEPTEMBER 23, 2009 COUNCIL OF THE CONVENTION SECTION ON THE QUALITY OF FOOD INGREDIENTS AND DIETARY SUPPLEMENTS INTRODUCTION The 1994 Dietary Supplement

More information

Political Economy of the Medical Products Industry

Political Economy of the Medical Products Industry Political Economy of the Medical Products Industry Tom Hazlet Survey of Biomedical Regulatory Affairs Spring 2008 Menu Definitions medical products political economy Commodities drugs devices biologics

More information

Photos of University Clocktower if they send them to me!!!!!!!

Photos of University Clocktower if they send them to me!!!!!!! Photos of University Clocktower if they send them to me!!!!!!! Assessment of Dietary Supplement Use in New Zealand: Methodological and Regulatory Challenges W Parnell, A van Rij, C Blakey, L Fleming, J

More information

COUNTERFEIT DRUGS IN INDIA

COUNTERFEIT DRUGS IN INDIA COUNTERFEIT DRUGS IN INDIA a part presentation from the on-going dissertation Global Threat of Counterfeit Drugs A Study Covering Extent of Problem and Anticounterfeit Measures in Europe & India By, Viraj

More information

RESULTS AT A GLANCE. FDA Oversight of Tobacco Manufacturing Establishments. HHS OIG Data Brief August 2017 OEI

RESULTS AT A GLANCE. FDA Oversight of Tobacco Manufacturing Establishments. HHS OIG Data Brief August 2017 OEI HHS OIG Data Brief August 2017 OEI-01-15-00300 FDA Oversight of Tobacco Manufacturing Establishments RESULTS AT A GLANCE The Tobacco Control Act authorized FDA to regulate domestic tobacco manufacturers

More information

Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products

Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products [In Confidence] Office of the Associate Minister Health Chair, Cabinet Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products Proposal

More information

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements CFSAN-FDA General Labeling Provisions FDA s authority to regulate

More information

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016

More information

Mark M. Yacura. Partner

Mark M. Yacura. Partner Mark M. Yacura Partner Mark M. Yacura focuses his practice primarily on FDA legal and regulatory matters. He has practiced in this area for more than 30 years. He represents his clients before administrative

More information

GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS

GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS 1 CAC/GL 23-1997 GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS CAC/GL 23-1997 Nutrition claims should be consistent with national nutrition policy and support that policy. Only nutrition claims that

More information

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients 18 th Presidential Commission for the Study of Bioethical Issues August 20, 2014 Washington, DC Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients Freddie Ann Hoffman,

More information

E-Siong Tee, PhD Scientific Director, ILSI SEA Region

E-Siong Tee, PhD Scientific Director, ILSI SEA Region E-Siong Tee, PhD Scientific Director, ILSI SEA Region (nutrihealth.tes@myjaring.net) 1 Background. Health claims permitted in some countries in SEA region mostly arising from applications from food industry

More information

POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT

POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC DG SANCO 2010 PUBLIC CONSULTATION DOCUMENT Answer given by the General Direction of Public Health of the Spanish Ministry of Health and Social

More information

Food and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law

Food and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law Food and Drug Law Fall 2009 Syllabus Professor Jesson Hamline University School of Law General course Information: Course: Food and Drug Law Credits: 2 Classroom: Law 103 Time: Thursdays, 4-5:50 p.m. Professor:

More information

Overview of Regulatory Science of Food Contact Substances

Overview of Regulatory Science of Food Contact Substances Overview of Regulatory Science of Food Contact Substances Michael A. Adams, PhD Deputy Director, Office of Food Additive Safety FDA, Center for Food Safety and Applied Nutrition 5001 Campus Drive, College

More information

December 4, 2017 VIA ELECTRONIC SUBMISSION

December 4, 2017 VIA ELECTRONIC SUBMISSION VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement

More information

The opinions expressed are the speaker s and not his company s.

The opinions expressed are the speaker s and not his company s. May 13, 2010 James Brooks, Ph.D. Vice President, Science & Technology Christine Burdick-Bell, J.D. Vice President, Legal & Regulatory Affairs Pharmavite LLC The opinions expressed are the speaker s and

More information

10 th Seminar on. Nutrition Labeling, Claims and Communication Strategies. Health Claims in Japan. What scientific evidence are we looking for?

10 th Seminar on. Nutrition Labeling, Claims and Communication Strategies. Health Claims in Japan. What scientific evidence are we looking for? 10 th Seminar on Nutrition Labeling, and Communication Strategies August 28 29, 2018 Renaissance Hotel, Kuala Lumpur, Malaysia Health in Japan What scientific evidence are we looking for? Organizers Co-organizer

More information

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated

More information

The science behind labeling issues and health claims a European perspective

The science behind labeling issues and health claims a European perspective 2005 CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Bioactive Food Components The science behind labeling issues and health claims a European perspective Dr Michele Kellerhals Scientific and

More information

OFFICIAL STATE BULLETIN

OFFICIAL STATE BULLETIN No. 280 Saturday 18 November 2017 Sec. I. Page 111191 I. GENERAL PROVISIONS HEAD OF STATE 13277 Royal Decree-Law 17/2017, of 17 November, amending Law 28/2005, of 26 December, on health measures against

More information

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,

More information

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM July 3, 2018 VIA ELECTRONIC SUBMISSION Agricultural Marketing Service Docket Clerk 1400 Independence Ave. SW Room 4543-South Washington, DC 20250 Re: Proposed Rule: National Bioengineered Food Disclosure

More information

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental

More information

Crossing the Line. When does innovative therapy become research?

Crossing the Line. When does innovative therapy become research? Crossing the Line When does innovative therapy become research? Presentation Overview Importance of Distinction Primary Research Regulators HHS FDA Tricky Situations Innovative surgery Quality improvement

More information

Regulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division

Regulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division Regulatory Systems of Health Claims in Japan June, 2011 Consumer Affairs Agency Food Labelling Division Mission of the Consumer Affairs Agency (CAA) Article 2 of the Consumer Basic Act sets out the state

More information

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Food Ingredients Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Disclosures Think Healthy Group, Inc. George Mason University, Department of Nutrition and Food Studies Journal of the American College

More information

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business To facilitate compliance with Regulations 5(1)(d), 5(1)(h) and 10 of the Regulation of Retail

More information

2.1 Naming of foods that are not covered by the scope of existing milk product standards

2.1 Naming of foods that are not covered by the scope of existing milk product standards Agenda Item 7 CX/MMP 04/6/11 February 2004 JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON MILK AND MILK PRODUCTS Sixth Session Auckland, New Zealand, 26 30 April 2004 DISCUSSION PAPER ON THE

More information

Australian Jurisdictional Update September 2018

Australian Jurisdictional Update September 2018 Australian Jurisdictional Update September 2018 Dr Elizabeth McGrath Strategic Adviser Medical Devices and Product Quality Division Department of Health Overview The Australian Government s Expert Review

More information